HEATR1 and neoplasm: By the time brat-deficient TICs start to overproliferate, HEATR1 inhibition continues to have no effect in the proliferation of non-tumour lineages but it delays the overgrowth onset of brat tumours, with TIC proliferation rates remaining at levels comparable to those of controls.